Vanda Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VNDA and other ETFs, options, and stocks.About VNDA
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder.
CEOMihael Hristos Polymeropoulos
CEOMihael Hristos Polymeropoulos
Employees203
Employees203
HeadquartersWashington, District of Columbia
HeadquartersWashington, District of Columbia
Founded2002
Founded2002
Employees203
Employees203
VNDA Key Statistics
Market cap277.33M
Market cap277.33M
Price-Earnings ratio110.55
Price-Earnings ratio110.55
Dividend yield—
Dividend yield—
Average volume3.86M
Average volume3.86M
High today$4.89
High today$4.89
Low today$4.65
Low today$4.65
Open price$4.68
Open price$4.68
Volume821.76K
Volume821.76K
52 Week high$7.00
52 Week high$7.00
52 Week low$3.30
52 Week low$3.30
VNDA News
Yahoo Finance 6d
Vanda Pharmaceuticals Stock Sinks As Market Gains: What You Should Know - Yahoo FinanceIn the latest trading session, Vanda Pharmaceuticals (VNDA) closed at $4.56, marking a -1.51% move from the previous day. This change lagged the S&P 500's 0.02%...